Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
The grossly overpaid CEO hasnt' ever actually bought any shares here. He earns a ludicrous amount, something like $350k including a bonus last year which the share price has dropped by 80%. In order to reassure shareholders all is well he should buy a meaningful amount of shares.
Yes, its been a relay of sellers between TB, GB and PM. Very frustrating and will have put off buyers. But as you say the figures do indeed speak for themselves and on the current run rate we could easily be on a PE of around 2 at the current share price.
Paul Morrfew has always been open about his intentions regarding holding/selling for anybody that cares to ask.
The company is ticking along nicely and an awful lot has been achieved in the last 18 months or so, turning around the business from a significant loss to an even larger profit, winning new contracts across both divisions and streamlining the operations.
But this is just the start. We are merely approaching the foothills of where i believe this company is heading. Once the near term catalysts of the debt refinancing and update on current trading are released along with the FY audited results I expect the share to re-rate.
Looking beyond this I would expect to see acquisitions of complimentary businesses and exponential growth in profit. Sit back and enjoy the ride.
Morning, definitely not me! The majority of the UK nominee accounts have actually increased their holdings in recent weeks/months. Assume it’s a few people with a non notifiable holding. Once we finally start to see some decent newsflow things will start moving upwards
Guess that shareholders fancy their chances of realising some value as a listed entity, which is fair enough. Agree that the business seems pretty screwed though
Great post Scott. Very optimistic here
"I have worked in the medical device business for 30 years, and as an entrepreneur in the field for the last 15 years, seeking out opportunities to improve patient healthcare and create outstanding value for shareholders. Often this work has been focused on producing a better, more efficient tool for use in the operating room. The improvements in health care delivery have been important, but relatively small, yet the businesses have been financially successful.
When I was approached by Flying Brands to become their COO, and the CEO of their operating businesses, what immediately struck me was the opportunity to be the architect in the way that healthcare is delivered. This is an opportunity for a leap in healthcare, not the creeping change I have previously successfully delivered. A healthcare revolution, not the evolution I have previously managed.
Imagine a world where expensive and invasive medical treatments are only used on patients that truly need it. Currently, resource consuming and painful biopsies are sought to confirm the presence or absence of disease in the face of ambiguous results from medical imaging. In an average hospital, hundreds of scans are taken daily, searching for disease. Imagine a software that is capable of detecting diseased patients and differentiating them from healthy patients, allowing healthcare practitioners to focus their care on the patients that need it the most. Imagine a software that improves its diagnostic capability over time, becoming more intelligent with each successful diagnosis and providing this knowledge and 'Artificial Intelligence' to those responsible for our healthcare.
I believe that Flying Brands through its operating businesses, has the capability to develop the software able to deliver such a revolution ".
99% of transactions on AIM listed shares go through the market makers. there are occasional transfers of shares from one holder to another that go from broker to broker but these tend to be for larger amounts.
Yes, I agree we need to get to the bottom of the companies intentions going forward and what assets they actually own and the value of these assets are calculated. I have never come across a company so adverse to promotion. It’s almost as if they don’t want shareholders to buy in and yet the directors own a decent percentage themselves so it is their interests that the share price rises.
Their model as i understand it is that, where possible, the PLC (or possibly now the newly incorporated Marechale Investments which is wholly owned by the PLC) take part payment in equity in the project they are providing funding for. Aside from the solar project the company have never been clear about what else they have equity in. All we have is the amounts mentioned in Investments for sale which may or may not represent the value of their share per the last funding round. My guess is that the new Investment company will be used to house all of the investments going forward and possibly beef up this side of the business. However, in the absence of any commentary from the company other than to pour cold water on any optimism we are left, as ever, in the dark.